Verum Diagnostica GmbH
http://www.multiplate.net
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Verum Diagnostica GmbH
Start-Up Quarterly Statistics, Q4 2011
Biopharma start-ups raised $693 million in Q4 2011, up 131% from Q3. Device companies brought in $111 million, and diagnostics firms raised $120 million total, $96 million of which was from Biocartis’ Series C. Cancer was the most prevalent therapeutic area for biopharma alliances. And in great contrast to Q3’s one M&A deal involving a start-up company, Q4 saw nine start-up acquisitions.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Deals Shaping The Medical Industry (01/2012)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
-
In Vitro Diagnostics
- Hematology, Coagulation
- Therapeutic Drug Monitoring
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice